Vor Biopharma (VOR) has transformed into a late-stage autoimmune drug developer, focusing on telitacicept, a dual BAFF/APRIL ...
What to expect from security around downtown Atlanta, LIVE on Channel 2 Action News This Morning from 4:30 a.m. to 9 a.m.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results